HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ethylene vinyl alcohol copolymer (Onyx) to seal type 1 endoleak. A new technique.

Abstract
The aim of this study was to investigate whether the liquid embolic agent Onyx, an ethylene vinyl alcohol copolymer, can be used to seal type 1 endoleaks during endovascular aortic repair (EVAR). Six patients with large aortic aneurysms and remaining type 1 endoleaks during or after EVAR were treated with Onyx embolization through a microcatheter placed in the proximal neck in five cases and in the distal neck in one case. Four of the patients were treated using the chimney technique. The type 1 endoleak was primarily sealed by Onyx in all six patients. There was no distal embolization. Two patients had complications during follow-up. One patient had occlusions of chimney grafts to the renal arteries and to one leg extension. These occlusions were not anatomically related to Onyx embolization. One patient had late stentgraft migration of the Onyx-treated distal neck with aneurysm rupture 18 months after treatment. Early experience of Onyx embolization as a bailout solution of type 1 endoleaks after complicated EVAR is promising. However, effective seal with Onyx does not prevent late stentgraft migration. More reported patients and longer follow-up are necessary to evaluate this new technique.
AuthorsOlof Henrikson, Håkan Roos, Mårten Falkenberg
JournalVascular (Vascular) Vol. 19 Issue 2 Pg. 77-81 (Apr 2011) ISSN: 1708-5381 [Print] England
PMID21489932 (Publication Type: Journal Article)
Chemical References
  • Onyx copolymer
  • Polyvinyls
  • Dimethyl Sulfoxide
Topics
  • Aged
  • Aged, 80 and over
  • Aortic Aneurysm (surgery)
  • Blood Vessel Prosthesis Implantation (adverse effects)
  • Dimethyl Sulfoxide (therapeutic use)
  • Embolization, Therapeutic (methods)
  • Endoleak (therapy)
  • Endovascular Procedures
  • Female
  • Foreign-Body Migration (etiology)
  • Humans
  • Male
  • Polyvinyls (therapeutic use)
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: